Kimia Farma Financials
| KAEF Stock | IDR 550.00 5.00 0.90% |
Kimia |
Kimia Farma Stock Summary
Kimia Farma competes with Indofarma Tbk, Kalbe Farma, Wijaya Karya, Adhi Karya, and Jasa Marga. PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. Kimia Farma operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 11772 people.| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000070303 |
| Business Address | Jl Veteran No9, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | kimiafarma.co.id |
| Phone | 62 21 384 7709 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Kimia Farma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Kimia Stock, because this is throwing your money away. Analyzing the key information contained in Kimia Farma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Kimia Farma Key Financial Ratios
Kimia Farma's financial ratios allow both analysts and investors to convert raw data from Kimia Farma's financial statements into concise, actionable information that can be used to evaluate the performance of Kimia Farma over time and compare it to other companies across industries.| Return On Equity | -0.026 | |||
| Return On Asset | 0.0089 | |||
| Target Price | 2170.0 | |||
| Beta | -0.11 | |||
| Z Score | 0.6 |
Kimia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kimia Farma's current stock value. Our valuation model uses many indicators to compare Kimia Farma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kimia Farma competition to find correlations between indicators driving Kimia Farma's intrinsic value. More Info.Kimia Farma Persero is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kimia Farma's earnings, one of the primary drivers of an investment's value.Kimia Farma Persero Systematic Risk
Kimia Farma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kimia Farma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Kimia Farma Persero correlated with the market. If Beta is less than 0 Kimia Farma generally moves in the opposite direction as compared to the market. If Kimia Farma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kimia Farma Persero is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kimia Farma is generally in the same direction as the market. If Beta > 1 Kimia Farma moves generally in the same direction as, but more than the movement of the benchmark.
Kimia Farma February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kimia Farma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kimia Farma Persero. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kimia Farma Persero based on widely used predictive technical indicators. In general, we focus on analyzing Kimia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kimia Farma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 27.5 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.96 |
Other Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.